CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous...